Craniometrix
PrivateLast Round
Series A
Mar 30, 2026
Total Funding Raised
$51.5M
Momentum Score
50 /100
Company Overview
Craniometrix is a healthcare technology company developing a comprehensive care platform for Alzheimer's disease and dementia. Initially focused on an AI-powered screening test for early detection, the company has expanded its services to be a 'one-stop-shop' for dementia care. The platform offers care navigation, personalized care plans, 24/7 support, medication management, and caregiver support. Craniometrix partners with medical institutions and is a CMS-approved participant in the Medicare GUIDE Model, providing services to patients paid for by Medicare. The company's mission is to empower caregivers and healthcare providers with tools to manage dementia care effectively. A Y Combinator (W22) alumnus, the company has raised over $6 million from investors including Defy Partners, Quiet Capital, and Cathexis Ventures.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Patient Engagement, Medical AI, Telemedicine, Revenue Cycle
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Craniometrix Comps
Public and private peers based on sector, stage, and business model.
Craniometrix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 30, 2026 | ||||
| Series A | Feb 1, 2026 | ||||
| Series A | Jan 1, 2026 | ||||
| Seed | Aug 10, 2022 | ||||
| Accelerator | Mar 1, 2022 |
Craniometrix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| J Ventures | Series A, Seed |
| Defy Partners Management | Series A |
| Y Combinator | Series A, Seed, Accelerator |
| Cathexis Ventures | Series A, Seed |
| Rebel Fund | Seed |
| Quiet Capital | Series A, Seed |
| Olive Tree Capital | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 30, 2026
$15M round completed.
- Feb 1, 2026
$15M round completed.
Craniometrix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Craniometrix's valuation, stock price, and market status.
